Gilead Sciences has agreed to purchase the remainder of improvement accomplice Arcellx in a deal that values the biotechnology firm at about $7.8 billion at closing.
Source link
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion
Related Posts
New IRS requirements will make crypto ‘tax cheat’ risky for this year
With year-end approaching, it is a good time to verify your tax home is so as. It is particularly vital…
Gartner Recommends Avoiding AI Browsers — for Now
Gartner is urging organizations to dam AI browsers, warning that agentic searching instruments can expose delicate knowledge, undermine safety controls,…
Study Finds Most Restaurants Missing From AI Recommendations
AI search is altering how diners uncover eating places, with Native Falcon analysis discovering many eateries seen on Google Maps…